* Meta-terms correspond to biological or medical specialty concerned
with one or more keywords (or keywords hierarchies), qualifiers, or resource types.
Other terms also benefit from this structure, when the topic warrants it, eg education.
See the list.
Preferred Label : risk management;
True Meta (CISMeF) : O;
Origin ID : MT111;
MeSH
- Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-marr/tocilizumab-1
2024
false
false
false
France
French
risk management
tocilizumab
infusions, intravenous
injections, subcutaneous
guidelines for drug use
tocilizumab
tocilizumab
patient education handout
continuity of patient care
tocilizumab
---
https://ansm.sante.fr/tableau-marr/sarilumab
2024
false
false
false
France
French
risk management
continuity of patient care
drug information
injections, subcutaneous
antibodies, monoclonal, humanized
sarilumab
patients guideline
---
https://publications.msss.gouv.qc.ca/msss/document-003698/
2024
Canada
scientific and technical information
algorithms
genets
genetics
gene, nos
Clinical Trial Eligibility Criteria
mars
Genetic Testing
Handbook
insurance
Interpretation
genetta, nos
cytisus
interpreter
Department
March
Software Service
Guide Device
viverridae
Algorithm
---
https://www.anses.fr/fr/system/files/BIORISK2021SA0019Ra.pdf
https://www.anses.fr/fr/system/files/BIORISK2021SA0019Ra-Anx-13.pdf
2024
France
technical report
cost savings
protestantism
Adverse Event Definitely Related to Intervention
judgment
Some
bays
albumin/globulin ratio
genomics
Genome
Economics
Medium Growth Rate
Approximate
risk
CDISC SDTM Risk Assessment Terminology
Device Evaluation Method
Relative Risk
Evaluation Method
economics
relative risk
Obtain
A Medium Amount of Time
environment
Growth Medium
Media
socioeconomic factors
health risk appraisal
hazardous substances
Medium Heart Murmur
evaluation report
plant, nos
Moderately Bothered
plants
Technique
Environmental
Health Risk Assessment
Certain
Hazard Ratio
genome
evaluation studies as topic
Plant
genome, plant
Neither Agree or Disagree
Middle Lobe of the Prostate
genome, nos
Middle
Surrounding
inlets
health status indicators
---
https://www.has-sante.fr/jcms/p_3500291/fr/flash-securite-patient-patient-tracheotomise-en-service-de-soins-critiques-tracheo-quand-la-vie-ne-tient-qu-a-un-tuyau
2024
France
scientific and technical information
has patient
Life
trachea, nos
Safety
patient safety
Vietnamese Language
Laser-Induced Fluorescence Endoscopy
Hose Device
critical care
CASP8AP2 wt Allele
life
Safety Study
Care Of
VIE Regimen
Pipe
patient care
Patient Care
Pipe Dosing Unit
---
https://www.inrs.fr/media.html?refINRS=QR%20179
2024
France
journal article
What Month is it
viruses
risk
influenza a virus, h5n1 subtype
charadriiformes
Disease Transmission
Influenza A (H5N1) Virus
Contamination during Use
virus, nos
gull, nos
---
https://www.inrs.fr/media.html?refINRS=TM%2078
2024
France
journal article
Safety
occupational health
Safety Study
safety
Occupational Health
occupation, nos
---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related
---
https://www.cochrane.org/fr/CD012608/LIVER_la-modification-de-lapport-en-graisses-alimentaires-est-elle-benefique-ou-risquee-pour-les-personnes
2024
United Kingdom
review of literature
french abstract
Dietary Route of Administration
gallstones
Modification
Alteration
Cholelithiasis
dietary fats
What Month is it
risk
Amendment
grease, nos
Amendment Regulatory Submission
biliary calculus, nos
persons
Data Change Date
Bile Duct Stone
People
---
https://www.cochrane.org/fr/CD014687/NEUROMUSC_quels-sont-les-benefices-et-les-risques-des-traitements-non-chirurgicaux-et-chirurgicaux-du-nevrome
2024
United Kingdom
review of literature
french abstract
Non-Surgical
Usually Need Help from Another Person for Walking
Hard to Walk More Than One Block
Walking
Morton Neuroma
Morton Neuroma
Symptoms Interfered with Walking
pain, nos
walking
gait, nos
risk assessment
Forward
Raw
morton's metatarsalgia
Treatment Benefit
risks and benefits
What Month is it
ball of foot
Foot Pain
pain
---
https://minerva-ebp.be/Theme/Analysis/857
2024
Belgium
critical appraisal or critical reading
Effect, Appearance
Parkinson's Disease Pathway KEGG
Preventive Intervention
parkinson's disease, nos
Outcome of Therapy
What Month is it
parkinson disease
persons
accidental falls
No Effect
Parkinson Disease
People
disease
---
https://dares.travail-emploi.gouv.fr/publication/comment-les-employeurs-previennent-ils-les-risques-professionnels
2024
France
journal article
risk
What Month is it
Employer
---
https://www.inrs.fr/media.html?refINRS=AC%20184
2024
France
journal article
Exhibition
neoplasm, malignant
cancer
Cancer Risk
Exposure Domain
europe
risk factor
Survey
risk factors
risk factor for malignancy
Exposure
Inquiry
neoplasms
occupational neoplasms
effects of exposure to external cause, nos
data collection
No Risk Factors
detective
Occupational Malignant Neoplasm
Investigation
occupational exposure
---
https://www.inrs.fr/media.html?refINRS=QR%20181
2024
France
journal article
Involvement
risk
Hepatitis C Virus Positive
disease
hepatitis, nos
Fix
What Month is it
Disease Transmission
hepatitis
Hepatitis
---
https://www.inrs.fr/media.html?refINRS=TF%20315
2024
France
journal article
Gene Amplification Positive
Tiredness Visual Analogue Scale
Sector
Alcohol Use Disorder Identification Test Self-Report Version Questionnaire
Audit Object
fatigue
Enhancer
Amplifier Device
audition, nos
Fatigue
Hearing
risk
Auditory
Bothered by Tiredness
Audit
Fatigue Subordinate Domain
hearing
amplifiers, electronic
ear, nos
music
EGFR Gene Amplification
auditory fatigue
---
https://iris.who.int/bitstream/handle/10665/376333/WHO-WHE-EPP-2024.3-fre.pdf
2024
Switzerland
public health guidelines
Montreal Cognitive Assessment Orientation Test
Biological Son
Biological or Textual Reference to Actual Test or Parameter
CDISC ADAS-Cog - Orientation Summary Score
orientation
biology
Clinical Trial Notification of Safety Information
Referral
Biological
Biological Challenge Agent
SARS Coronavirus
laboratory reporting, nos
Biology
biology
Institutional Review Board Independent Ethics Committee Notification of Safety Information
Document
SARS-CoV-2
safety
containment of biohazards
Direction
Orientation
Referring
Safety Report
laboratories
COVID-19 Infection
Biological Agent
orientation, nos
research report
COVID-19
---
https://www.has-sante.fr/jcms/p_3502633/fr/flash-securite-patient-transport-intrahospitalier-des-patients-de-soins-critiques-le-transport-lui-aussi-est-critique
2024
France
guideline
tool, nos
professional practice
transportation of patients
Patient Navigation
Safety
Improved
Tool
Professional Practice
Safety Study
patient transfer
evaluation studies as topic
Enhance
CASP8AP2 wt Allele
carrying
patient safety
Veterinary Patient
patient care
has patient
Scientific Equipment
critical care
---
https://publications.msss.gouv.qc.ca/msss/document-003705/
2024
Canada
technical report
incidence
accident, nos
research report
Health Care Delivery
albumin/globulin ratio
quebec
social work
delivery of health care
Social Health Service
socialism
accidents
Care Of
Occurrence
Regulatory Report
health services
Ratio
---
https://minerva-ebp.be/FR/Article/2370
2024
Belgium
critical appraisal or critical reading
knee prosthesis
Smartphone Application
supervision
Limburgish Language
Surgical Procedure was Curative Therapy
residence characteristics
Smartphone
Knee Joint
What Month is it
attention
rehabilitation
Efficacy Study
operative procedure, nos
prosthesis, nos
general surgery
domicile
Safety Issue Application
Surgical Procedure
Shawnee
safety
Management
efficiency
Prosthesis Device Component
Overdenture
---
https://www.cochrane.org/fr/CD014544/CF_quels-sont-les-benefices-et-les-risques-des-nouveaux-traitements-par-facteurs-non-coagulants-pour-la
2024
United Kingdom
review of literature
french abstract
risk factors
blood coagulation factors
hemophilia B
bloodletting
coagulants
Treatment Benefit
Feeding
Breeding
Risk Factor
Coagulation Factor
hemophilia b, nos
persons
risks and benefits
risk factor
F9 wt Allele
Feeding Ability
Prevention Study
Hemophilia B
What Month is it
disease
Raw
coagulation factor, nos
Hemorrhage
Preventive Intervention
risk assessment
bleeding precautions
hemorrhage
People
New Lesion Identification
Newar Language
preventive treatment, nos
---
https://www.cochrane.org/fr/CD015014/COLOCA_quels-sont-les-benefices-et-les-risques-de-loperation-roux-en-y-non-coupee-apres-ablation-de-la
2024
United Kingdom
review of literature
french abstract
risk assessment
Murine Stomach
NT5E wt Allele
neoplasm, malignant
Non-Surgical
Stomach
excision, nos
stomach, nos
malignant neoplasm stomach
stomach neoplasms
Raw
Cancer Therapeutic Procedure
operative procedure, nos
risks and benefits
stomach
Entity Name Data Type
cancer of stomach
surgical procedures, operative
Beyond
What Month is it
Post-Therapy
Ablation Therapy
---
https://www.academie-medecine.fr/les-punaises-de-lit-en-2024-realites-risques-et-impostures/
2024
France
scientific and technical information
risk
bedbugs
Bed
Buginese Language
cimex lectularius
Lithuanian Language
---
https://www.assurance-maladie.ameli.fr/etudes-et-donnees/depenses-risque-statistique-mensuelle
2024
France
scientific and technical information
expenditures
GDC Type Terminology
health expenditures
DUSP4 wt Allele
risk
---
https://www.cochrane.org/fr/CD003331/VASC_quels-sont-les-benefices-et-les-risques-de-la-readaptation-cardiaque-basee-sur-lexercice-pour
2024
United Kingdom
review of literature
french abstract
Cardiac Rehabilitation
risks and benefits
Heart Failure
exercise
heart failure, nos
What Month is it
risk assessment
post-cardiac rehabilitation training
Before Exercise
Exercise
Exercise Pain Management
Cardiac Rehabilitation
heart failure
---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/eculizumab-2
2024
false
false
false
France
French
risk management
eculizumab
eculizumab
eculizumab
guidelines for drug use
patient education handout
patients guideline
antibiotic prophylaxis
infusions, intravenous
Infections
sepsis
Drug-Related side effects and adverse reactions
meningococcal infections
vaccination
meningococcal vaccines
---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense
---
https://ansm.sante.fr/tableau-marr/etanercept-1
2024
false
false
false
France
French
risk management
Etanercept
patients guideline
drug information
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/dabigatran
2024
false
false
false
France
French
guidelines for drug use
risk management
Dabigatran
Dabigatran
dabigatran etexilate
administration, oral
antithrombins
antithrombins
continuity of patient care
hemorrhage
risk
adult
child
---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/tetradecyl-sulfate-de-sodium
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
sodium tetradecyl sulfate
sclerosing solutions
sodium tetradecyl sulfate
sodium tetradecyl sulfate
injections, intravenous
sclerotherapy
---
https://ansm.sante.fr/tableau-marr/teclistamab
2024
false
false
false
France
French
popular works
drug information
Teclistamab
risk management
teclistamab
---
https://ansm.sante.fr/tableau-marr/selexipag
2024
false
false
false
France
French
risk management
Uptravi
medication errors
selexipag
patients guideline
guidelines for drug use
Wrong dose
selexipag
---
https://ansm.sante.fr/tableau-marr/venetoclax
2024
false
false
false
France
French
risk management
venetoclax
venetoclax
patient education handout
tumor lysis syndrome
administration, oral
antineoplastic agents
---
https://ansm.sante.fr/tableau-marr/panobinostat
2024
false
false
false
France
French
risk management
Panobinostat
panobinostat
administration, oral
medication errors
patients guideline
patient compliance
---
https://ansm.sante.fr/tableau-marr/tacrolimus
2024
false
false
false
France
French
risk management
tacrolimus
tacrolimus
administration, oral
guidelines for drug use
patient education handout
continuity of patient care
immunosuppressive agents
---
https://ansm.sante.fr/tableau-marr/cladribine
2024
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests
---
https://ansm.sante.fr/tableau-marr/inebilizumab
2024
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection
---
https://ansm.sante.fr/tableau-marr/ponesimod
2024
false
false
false
France
French
risk management
ponesimod
ponesimod
administration, oral
ponesimod
ponvory
guidelines for drug use
patients guideline
pregnancy
continuity of patient care
ponesimod
adult
multiple sclerosis, relapsing-remitting
drug monitoring
immunosuppressive agents
immunosuppressive agents
immunosuppressive agents
---
https://ansm.sante.fr/tableau-marr/nalmefene
2024
false
false
false
France
French
risk management
nalmefene
nalmefene
guidelines for drug use
patient education handout
administration, oral
patient compliance
patients guideline
alcohol drinking
continuity of patient care
nalmefene
alcoholism
adult
algorithms
Psychosocial Intervention
---
https://ansm.sante.fr/tableau-marr/icodextrine
2024
false
false
false
France
French
risk management
guidelines for drug use
peritoneal dialysis
blood glucose self-monitoring
Icodextrin
---
https://ansm.sante.fr/tableau-marr/tolvaptan
2024
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout
---
https://ansm.sante.fr/tableau-marr/olanzapine
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Olanzapine
risk management
olanzapine
injections, intramuscular
Delayed-Action preparations
Olanzapine
metabolic diseases
continuity of patient care
drug compounding
injections, intramuscular
olanzapine pamoate
olanzapine pamoate
schizophrenia
antipsychotic agents
antipsychotic agents
medication errors
Post-injection delirium sedation syndrome (finding)
---
https://ansm.sante.fr/tableau-marr/insuline-glargine
2024
false
false
false
France
French
Insulin Glargine
medication errors
risk management
insulin glargine
guidelines for drug use
patients guideline
---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide
---
https://ansm.sante.fr/tableau-marr/pomalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide
---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet
---
https://ansm.sante.fr/tableau-marr/belatacept
2024
false
false
false
France
French
guidelines for drug use
risk management
BELATACEPT
immunosuppressive agents
infusions, intravenous
belatacept
patient education handout
Infusion-Related Reaction
infusions, intravenous
---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout
---
https://ansm.sante.fr/tableau-marr/glucagon
2024
false
false
false
France
French
guidelines for drug use
risk management
glucagon
glucagon
administration, intranasal
patient education handout
---
https://www.has-sante.fr/jcms/p_3240311/fr/flash-securite-patient
2024
France
guideline
Improved
Safety
patient safety
Professional Practice
tool, nos
Veterinary Patient
professional practice
occupational health
has patient
Enhance
Tool
Scientific Equipment
CASP8AP2 wt Allele
Safety Study
---
https://www.has-sante.fr/jcms/p_3502487/fr/flash-securite-patient-canicule-personnes-hospitalisees-et-hebergees-en-etablissement-medico-social-mettez-les-patients-au-frais-avant-qu-ils-n-en-fassent-les-frais
2024
France
guideline
strawberry
Recovered from Adverse Event
Inpatient Encounter
Healthcare Facility
Blackberry
Strawberry Flavor
Enhance
Safety Study
CASP8AP2 wt Allele
has patient
Tool
patient safety
tool, nos
residential facilities
Professional Practice
Institution
extreme heat
Strawberry
housing
Blackberry Flavor
professional practice
inpatients
fees and charges
socialism
persons
Improved
charges
Safety
Scientific Equipment
Social
hospital admission, nos
Inpatient
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1374
2024
France
public health guidelines
risk-taking
Catenin Delta-1
hemorrhagic fever, crimean
Coronavirus Anxiety Scale
CTNND1 wt Allele
Case
judgment
Congo-Crimean Hemorrhagic Fever
No Cases Transmission Pattern
relative risk
simian immunodeficiency virus
Prevention
fever
Human
True Case Status
Neither Agree or Disagree
Case Dosing Unit
Relative Risk
Prevention Study
bone screws
congo-crimean hemorrhagic fever
Charge
homo sapiens
BCAR1 wt Allele
risk
Preventive Intervention
snacks
humans
Breast Cancer Anti-Estrogen Resistance Protein 1
patient care management
Packaging Case
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-des-consultations-et-tests-preoperatoires-pour-une-chirurgie-elective-a-faible-risque-chez-les-personnes-de-16-ans-et-plus.html
2024
Canada
guideline
Consultation
International Prognostic Index Low Risk Group
Disease Risk Index Low Risk
IPSS-R Risk Category Low
Low Risk
operative procedure, nos
Autonomic Nervous System
Elective Surgical Procedures
Sixteen
Elective Surgical Procedure
asthenia
Drug Accumulation 1.2 to 1.99
American Samoa
American College of Cardiology/American Heart Association Lesion Complexity Score
A
persons
People
More
Human Papillomavirus-16
referral and consultation
Laboratory Procedure
consultants
risk
---
https://ansm.sante.fr/tableau-marr/ritlecitinib
2024
false
false
false
France
French
risk management
Ritlecitinib
Drug-Related side effects and adverse reactions
ritlecitinib
guidelines for drug use
patient education handout
administration, oral
Janus Kinase Inhibitors
Immunomodulating Agents
---
https://ansm.sante.fr/tableau-marr/dronedarone
2024
false
false
false
France
French
risk management
continuity of patient care
Dronedarone
Dronedarone
dronedarone
administration, oral
guidelines for drug use
patient education handout
atrial fibrillation
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
anti-arrhythmia agents
anti-arrhythmia agents
---
https://conseil-scientifique.public.lu/fr/publications/examens-laboratoire/osteoporose-2023.html
2024
Luxembourg
guideline
osteoporosis
Diagnosis Study
Fracture
osteoporosis
diagnosis
osteoporosis, nos
Diagnosis Code
risk assessment
fracture, nos
Charge
Fracture of Device/Material
osteoporotic fractures
no diagnosis
CDISC SDTM Risk Assessment Terminology
patient care management
Date of Diagnosis
Osteoporosis
Health Risk Assessment
risk-taking
---
https://www.ordre.pharmacien.fr/les-communications/focus-sur/les-autres-publications/la-securite-des-pharmaciens-d-officine-bilan-2023
2024
France
technical report
pharmacist
Safety Study
Balance Sheet
pharmacists
safety
Safety
Checkup
---
https://www.acadpharm.org/dos_public/AVIS_MICROPLASTIQUES_2024.04.10_VF.PDF
2024
France
scientific and technical information
environment
Surrounding
risk
Neither Agree or Disagree
Environmental
judgment
hazardous substances
Approximate
relative risk
Relative Risk
Microplastics
---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Biologie_medicale/INESSS_Pertinence_tests_preop_GUO.pdf
2024
Canada
practice guideline
People
Drug Accumulation 1.2 to 1.99
More
Low Risk
American Samoa
Sixteen
International Prognostic Index Low Risk Group
Autonomic Nervous System
Human Papillomavirus-16
Disease Risk Index Low Risk
American College of Cardiology/American Heart Association Lesion Complexity Score
A
risk
persons
asthenia
Elective Surgical Procedures
IPSS-R Risk Category Low
operative procedure, nos
Elective Surgical Procedure
---
https://www.inrs.fr/media.html?refINRS=NO%2041
2024
France
journal article
safety
New Lesion Identification
Supplies
social control, formal
Newar Language
Safety
Safety Study
---
https://ansm.sante.fr/tableau-marr/crizotinib
2024
false
false
false
France
French
patients guideline
patient education handout
drug information
risk management
Crizotinib
Crizotinib
continuity of patient care
crizotinib
vision disorders
adult
child
---
https://www.assurance-maladie.ameli.fr/etudes-et-donnees/donnees/liste-bases-de-donnees-open-data
2024
false
false
false
France
Open Access Publishing
databases as topic
open data
public health
insurance, health
scientific and technical information
---
https://www.inrs.fr/media.html?refINRS=ED%206169
2024
France
popular works
Biological Son
containment of biohazards
Remove
Biotechnology
biology
biology
Safety Study
hazardous substances
Withdraw
Biological Agent
chemical safety
Biological or Textual Reference to Actual Test or Parameter
Biological Challenge Agent
Safety
Biology
Biological
risk
---
https://kce.fgov.be/fr/publications/tous-les-rapports/depistage-du-cancer-du-poumon-chez-les-personnes-a-haut-risque
2024
Belgium
technical report
risk assessment
persons
cancer screening
lung cancer
risk
Screening for Lung Cancer
People
High-Risk Cancer
screening for cancer
early detection of cancer
lung neoplasms
---
https://ansm.sante.fr/tableau-marr/darvadstrocel
2024
false
false
false
France
French
risk management
Darvadstrocel
darvadstrocel
guidelines for drug use
guideline
medication errors
Darvadstrocel
drug storage
Infections
cold chain
temperature recording
---
https://www.cbip.be/fr/articles/4315?folia=4305
2024
false
false
false
Belgium
French
Dutch
journal article
colchicine
risk
risk management
Narrow Therapeutic Index
narrow therapeutic range drugs
---
https://www.assurance-maladie.ameli.fr/etudes-et-donnees/open-damir-depenses-sante-interregimes
2024
France
database
expenditures
Health Insurance
Complete Pharyngeal Contraction
Breast Cancer Surgeon was Thorough
Baseline
disease, nos
Dental Base
Baseline Epoch
Finish
Core Device
Nucleotide
health expenditures
Core Specimen
Full
Base of the Prostate
Complete Agreement
insurance, health
base, nos
---
https://ansm.sante.fr/tableau-marr/natalizumab-1
2024
false
false
false
France
French
Natalizumab
risk management
Natalizumab
natalizumab
guidelines for drug use
patient education handout
continuity of patient care
Drug-Related side effects and adverse reactions
opportunistic infections
leukoencephalopathy, progressive multifocal
immunologic factors
immunologic factors
multiple sclerosis
---
https://www.acadpharm.org/dos_public/LES_PHARMACIENS_SE_SONT_MOBILISES_POUR_ELARGIR_LACCESSIBILITE_VF.PDF
2024
France
scientific and technical information
disease
communism
news
pharmacist
Communication
Increased
Weekly
Prevention
National Health Insurance
communication
insurance, health
vaccination
Vaccination Coverage
Vaccination
disease, nos
Increase
vaccination
pharmacists
preventive immunization/medication
Prevention Study
vaccination, nos
Shared
---
https://www.cochrane.org/fr/CD013271/NEONATAL_quels-sont-les-benefices-et-les-risques-du-traitement-par-corticosteroides-des-prematures-presentant
2024
United Kingdom
review of literature
french abstract
adrenal cortical hormone, nos
Premature Infant
Bronchopulmonary Dysplasia
risk assessment
immature
What Month is it
Corticosteroid
adrenal cortex hormones
Too Early
Preterm Birth
bronchopulmonary dysplasia
infant, premature
corticosteroid therapy
risk
Treatment Benefit
risks and benefits
bronchopulmonary dysplasia of newborn
---
https://www.cbip.be/fr/articles/4328?folia=4319
2024
false
false
false
Belgium
French
journal article
valproic acid
risk management
Exposure to anticonvulsant (event)
paternal exposure
Neurodevelopmental Disorders
child
---
http://beh.santepubliquefrance.fr/beh/2024/9/2024_9_1.html
2024
France
journal article
french
hypertensive disease, nos
Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement
hypertension
france
risk
ethyl alcohol
Hypertension
Metropolitan France
cues
alcohol drinking
Alcohol Consumption
Impact
Alcohol Use History
---
https://cps.ca/fr/documents/position/securite-a-velo
2024
Canada
guideline
Safety
adolescent
safety
Offspring
bicycling
Teenager
Safety Study
child, nos
child
Improved
Child
adolescence
Adolescent
Adolescents
Enhance
---
https://dares.travail-emploi.gouv.fr/publication/salaries-prive-risques-activite-professionnelle-dispositifs-prevention
2024
France
journal article
Prevention Study
devices
Informative
Prevention
Active
Preventive Intervention
Oprelvekin
device, nos
Biochemical Activity
What Month is it
Device
occupations
risk
equipment and supplies
No Information Available
Private
FDA Establishment Activity Terminology
Informed
---
https://dares.travail-emploi.gouv.fr/publication/simple-comme-un-coup-de-fil-la-prevention-des-risques-dans-une-cellule-decoute
2024
France
journal article
work
stress, psychological
"u" lymphocyte
What Month is it
Filipino Language
Work
risk
Barrett Esophagus
Cell
Occupation
cells
occupation, nos
Simple Endometrial Hyperplasia
Cellular Telephone
GON4L wt Allele
Wire Device
psychosocial risk
Worksite
Preventive Intervention
Murine Cell Types
Computer Job
Prevention Study
Prevention
---
https://www.academie-medecine.fr/risques-pour-les-enfants-en-contact-etroit-avec-des-animaux-de-compagnie-non-traditionnels-acnt-dans-les-lieux-publics/
2024
France
scientific and technical information
NON Mouse
MET Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
PDGFRA Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
First Degree Family History Thyroid Cancer Negative
No History of Non-Cardiac Surgery
Therapeutic Ionizing Radiation to Head History Absent
RET Rearrangement Analysis Was Not Performed
No History of Rheumatic Fever
Physical Contact
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
Neither Case or Control Status
MGMT Promoter Methylation Testing Was Not Performed
Additional Surgery for New Tumor Event Absent
No Response to Intervention for Kawasaki Disease
SDH Complex Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
Contact Person
Family History of Stomach Cancer Absent
Any Metastatic Diagnosis Absent
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
ROS1 Rearrangement Analysis Was Not Performed
Unemployed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
NF1 Mutation Analysis Was Not Performed
No Known History of Alcohol Use
History of Colorectal Cancer Negative
No History of Neonatal Complication
Medication Not Taken
Documentation Absent
Paraneoplastic Syndrome is Not Present
KCNQ1 wt Allele
Tumor Progression Absent After Initial Treatment
EGFR Gene Amplification Negative
Caffeine Not Routinely Consumed
BRAF Mutation Analysis Was Not Performed
Cancer History Absent
Not Lost to Follow-Up
ATRX Gene Mutation Negative
Regional Anesthesia was not Administered
Nitric Oxide Measurement
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Offspring
Neither
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Additional Immunohistochemistry Was Not Performed
IDH Family Wildtype
Chemical/Occupational Exposure Absent
Adjuvant I-131 Therapy Negative
First Degree Family History Cancer Negative
risk
child, nos
Negation
Intervention Not Given for Kawasaki Disease
ATRX Mutation Analysis Was Not Performed
No Known History of Illicit Drug Use
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Nitric Oxide
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Patient was Not Previously Evaluated for Current Chief Complaint
First Degree Family History of Primary Brain Tumor Negative
Chief Complaint Not Caused by Trauma
Other Preoperative IV Medications were not Administered
Additional Molecular Studies Were Not Performed
EGFR Amplification Analysis Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation History Negative
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
EGFR Mutation Analysis Was Not Performed
Communication Contact
pets
1p/19q Deletion Analysis Was Not Performed
Chief Complaint was Not Witnessed
animal, nos
Preoperative IV Antacids were not Administered
New Tumor Event After Initial Treatment Absent
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
No History of Gestational Complication
Preoperative IV Opiates were not Administered
IV Anesthesia was not Administered
Narrow
panthera uncia
Has No Sibling
Adjuvant Post-operative Radiation Therapy Was Not Administered
Preoperative IV Antiemetics were not Administered
KIT Mutation Analysis Was Not Performed
Radiation Therapy Not Received
New Disease is not Multifocal
Adjuvant Post-operative Chemotherapy Was Not Administered
PTEN Mutation Analysis Was Not Performed
History of Medical Treatment Absent
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Physician Diagnosed Diabetes Absent
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Chemotherapy Not Received
No History of Myopathy
PTEN Gene Mutation Negative
Minor Criteria for Rheumatic Heart Disease Not Present
ERBB2 Mutation Analysis Was Not Performed
TP53 Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Norway
Patient was not Postmenopausal with no Prior Oophorectomy
IDH Family Mutation Analysis Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
NRAS Mutation Analysis Was Not Performed
No History of Kawasaki Disease
Child
Routine Cytogenetics Were not Completed
Preoperative IV Sedation was Not Administered
child
Another Form of Birth Control was not Used
ALK Rearrangement Analysis Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
No History of Congenital Heart Disease
Hypertension Absent
Use of Smokeless Tobacco at Time of Diagnosis Negative
Fluorescence In Situ Hybridization Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
10q23/PTEN Locus Deletion Analysis Was Not Performed
Public
narrowing, nos
---
https://www.has-sante.fr/jcms/p_3511526/fr/flash-securite-patient-surveillance-des-patients-en-service-de-soins-critiques-une-veille-sans-faille-pour-qu-aucun-patient-ne-defaille
2024
France
guideline
Risk Factor History Negative
Null
Drug Accumulation Less than 1.2
None Device
Desmosine
critical care
patient care
CASP8AP2 wt Allele
No Hand Mobility
Patient Care
Use_For
No Support Needed
patients
patient safety
Non-Neoplastic Finding Absent
No Exacerbating Factor to Chief Complaint
custodial care
WWOX wt Allele
Safety Monitoring
No Signs and Symptoms Associated with Chief Complaint
professional practice
Care Of
Professional Practice
No Alleviating Factor to Chief Complaint
failure, nos
USH1G wt Allele
Patient Monitoring
Patient
No Effort
Human Papillomavirus Negative
has patient
---
https://www.anses.fr/fr/content/preparez-les-beaux-jours-en-toute-securite
2024
France
popular works
Every Seven Days
safety
Preparation
Daily
Day
Safety Study
Safety
---
https://www.cochrane.org/fr/CD015112/OCCHEALTH_quels-sont-les-benefices-et-les-risques-des-interventions-sur-le-lieu-de-travail-visant-reduire-le
2024
United Kingdom
review of literature
french abstract
SARS Coronavirus
health
Worksite
hazardous substances
Sector
Adverse Event Associated with Infection
workplace
risks and benefits
potential for infection
What Month is it
risk assessment
risk
Infection
SARS-CoV-2
occupation, nos
---
https://osha.europa.eu/fr/publications/strategies-safety-and-health-automated-world
2024
France
scientific and technical information
Strategy
Safety Study
State Machine
world health
robot
Automatic
automatism
Safety
automatism
safety
Global Health
GDC Procedures Performed Terminology
---
https://www.has-sante.fr/jcms/p_3483264/fr/fluenz-tetra-vaccin-grippal-quadrivalent-vivant-attenue-nasal-vaccin-antigrippal
2024
false
false
false
France
evaluation of the transparency committee
Trivalent Live-Attenuated Influenza Vaccine
preventive immunization/medication
Nasal Route of Administration
Trial Element Duration
Influenza Vaccine
influenza virus vaccine
vaccines, attenuated
Quadrivalent Influenza Vaccine
Nasal Dosage Form
vaccination
nose, nos
influenza vaccines
Tea Leaf
Ezatiostat Hydrochloride
attenuated by
---
https://assurance-maladie.ameli.fr/etudes-et-donnees/par-theme/risques-professionnels-et-sinistralite/accidents-de-trajet
2024
France
scientific and technical information
accident, nos
accidents
accidents, traffic
Occurrence
---
https://assurance-maladie.ameli.fr/etudes-et-donnees/par-theme/risques-professionnels-et-sinistralite/accidents-du-travail
2024
France
scientific and technical information
accident while engaged in work-related activity, nos
Worksite
Occurrence
Work
accidents, occupational
Computer Job
work-related activity accident, nos
Occupation
---
https://dares.travail-emploi.gouv.fr/publication/quelle-prevention-des-risques-physiques-et-chimiques-pour-les-sortants-de-la-voie
2024
France
journal article
physics
Prevention
risk
Sontuzumab
Preventive Intervention
What Month is it
Route of Administration
Prevention Study
CDISC SDTM Route of Administration Terminology
---
https://ansm.sante.fr/tableau-marr/inhibiteur-de-la-c1-esterase-humaine
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
Human C1-Esterase Inhibitor
patients guideline
---
https://ansm.sante.fr/tableau-marr/elranatamab
2024
false
false
false
France
French
risk management
Elranatamab
drug information
patients guideline
Cytokine Release Syndrome
nervous system diseases
---
https://www.irdes.fr/documentation/syntheses/la-prise-en-charge-des-accidents-du-travail-et-l-organisation-de-la-medecine-du-travail-en-france.pdf
2024
France
french abstract
Charge
work-related activity accident, nos
france
organizers, embryonic
Appearance
organizations
history
historical aspects
patient care management
accident while engaged in work-related activity, nos
french
with pattern
accidents, occupational
Organization
workload
Organization Name
Occurrence
organization
Appearance Distress
Occupational Medicine
occupational medicine
Other Agency or Organization
CHFR Gene
---
https://www.inrs.fr/media.html?refINRS=TS855page44
2024
France
journal article
Safety
Safety Study
safety
---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-liees-au-travail/maladies-a-caractere-professionnel/documents/rapport-synthese/priorisation-des-couples-maladie-facteur-de-risque-pour-l-estimation-du-fardeau-environnemental-et-professionnel-de-la-maladie-en-france
2024
France
technical report
Health Care Professional Promotional Material
Risk Estimate
appraiser
Disease Steps Clinical Classification
france
tularemia
CHFR Gene
family characteristics
risk factors
tularemia, nos
Professional Occupation
environmental illness
risk factor
couples
risk assessment
Couple
Disease Free
Environmental Risk Factor
Disease Object
cost of illness
occupational diseases
hazardous substances
Coupler Device
Burden
No Evidence of Coronary Artery Disease
---
https://ansm.sante.fr/tableau-marr/susoctocog-alfa
2024
false
false
false
France
French
risk management
Susoctocog Alfa
medication errors
guidelines for drug use
drug dosage calculations
video recording
---
https://cps.ca/fr/documents/position/le-jeu-risque-exterieur
2024
Canada
public health guidelines
injury, nos
risk
child development
Child Individual
Injury
Healthy
Development Batch
injuries
Outdoors
Prevention Study
wounds and injuries
child, nos
Preventive Intervention
Outer
play
Balance
Prevention
Child Relation
Development Lot
Balanced Translocation
play and playthings
Maturation
---
https://www.inrs.fr/media.html?refINRS=FO%2040
2024
France
journal article
Preventive Intervention
risk
gait
identified
Prevention Study
Machinery Heart Murmur
gait, nos
Goes Out
machine, nos
Prevention
Usually Need Help from Another Person for Arising
---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous
---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Cancers-de-la-peau-s-informer-sur-les-risques-et-se-proteger-brochure
2024
France
patient education handout
Informed
Slice
Informative
Claudin-6
Go Skating
Murine Skin
Oprelvekin
Tiludronate Disodium
Ivermectin
No Information Available
Thaw
skin
Skin
risk
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-du-diabete-de-type-2-et-evaluation-du-risque-cardiovasculaire.html
2024
Canada
technical report
Cardiovascular Risk
Last Screening
Eligibility Determination
Genetic Screening
Trial Screening
Health Risk Assessment
Murine Cardiovascular System
Type 2 Diabetes Mellitus
Site Screening
Cancer Screening
mass screening
diabetes non-insulin dependent
screening for diabetes
screening
risk assessment
diabetes mellitus, type 2
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Screening Study
Cardiovascular
Cardiovascular System
cardiovascular risk
Substance Screening
---
https://www.louvainmedical.be/fr/article/prevention-primaire-les-cobenefices-pour-la-sante-et-lenvironnement
2024
Belgium
journal article
preventive medicine
Environmental
principal
Approximate
Surrounding
Primary Prevention
primary prevention
environmental health
---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2024-vedolizumab-ustekinumab-anti-tnf-grossesse-mici
2024
France
scientific and technical information
safety
TNF Gene
Ustekinumab
inflammatory bowel disease, nos
tumor necrosis factor
Institutional Review Board Independent Ethics Committee Notification of Safety Information
Document
Physically Feel in Bad Condition
tumor necrosis factors
Safety Report
Clinical Trial Notification of Safety Information
chronic disease, nos
Vedolizumab
research report
vedolizumab
disease
Tumor Necrosis Factor
anti-TNF
Ustekinumab
Chronic Disease
pregnant women
inflammatory bowel diseases
vedolizumab
pregnancy, nos
albumin/globulin ratio
chronic disease
Gravida
---
https://www.has-sante.fr/jcms/p_3415710/fr/strategie-de-vaccination-contre-la-covid-19-place-du-vaccin-comirnaty-bivalent-original/baba-4-5-10-g/dose-dans-la-strategie-de-rappel-des-enfants-de-5-a-11-ans-revolus-a-risque-de-forme-grave
2024
France
public health guidelines
Vaping
Offspring
Severity Four Out of Five
risk
Recollect
child, nos
severe
health planning guidelines
Eleven
COVID-19 Vaccines
Loss of Chromosome 11
vaccination
Callback
Reminder
Per Hundred Thousand
Bivalent Vaccines
Serious Risk
Recommendation
Strategy
Per Ten Thousand
Vaccination
Child
preventive immunization/medication
child
Vaccine
Placement
vaccination
Booster
vaccinia virus vaccine
Autonomic Nervous System
---
https://www.has-sante.fr/jcms/p_3494049/fr/experimentation-par-la-has-de-la-methode-de-labellisation-d-indicateurs-concus-par-des-organismes-externes-pour-l-amelioration-de-la-qualite-et-de-la-securite-des-soinsa-partir-de-2024
2024
France
technical report
Outer
Organisms Category
quality improvement
organizations
protestantism
nursing
Technique
organ part
Enhance
Test Method
indicators and reagents
Improved
safety
Health Care Organization
Methodology
Quality of Care
Labeled
External Route of Administration
Pars Externa
indication of
Safety Study
Safety
suggestive of
CDISC SDTM Method Terminology
---
https://ansm.sante.fr/tableau-marr/aciclovir
2024
false
false
false
France
French
guideline
patients guideline
drug information
risk management
acyclovir
Accidental Drug Ingestion
Muco-adhesive Buccal Tablet Dosage Form
---
https://ansm.sante.fr/tableau-marr/methotrexate-per-os
2024
false
false
false
France
French
guidelines for drug use
risk management
methotrexate
administration, oral
patient education handout
medication errors
---
https://ansm.sante.fr/tableau-marr/adalimumab
2024
false
false
false
France
French
Adalimumab
risk management
continuity of patient care
drug information
adult
child
patient education handout
---
https://sante.gouv.fr/IMG/pdf/feuille-de-route-medicaments-fevrier-2024.pdf
https://sante.gouv.fr/actualites/presse/communiques-de-presse/article/penuries-de-medicaments-la-ministre-du-travail-de-la-sante-et-des-solidarites
2024
France
technical report
Nutritional Supplement Drink
insurance, pharmaceutical services
industry
GDC Therapeutic Agent Terminology
insurance coverage
Date Available
Availability
drug insurance
drug, nos
drug industry
Long-Term
Pharmacologic Substance
---
https://www.cochrane.org/fr/CD013789/MUSKINJ_les-interventions-basees-sur-la-population-celles-qui-visent-des-communautes-entieres-plutot-que-des
2024
United Kingdom
review of literature
french abstract
attentiveness
Injury
Quite a Bit
injuries
aged
Population Intervention
aged, 80 and over
accidental falls
population
injury, nos
persons
Elderly
residence characteristics
community
elderly person, nos
wounds and injuries
What Month is it
---
https://www.cochrane.org/fr/CD015432/SYMPT_quels-sont-les-benefices-et-les-risques-de-libuprofene-dans-la-prise-en-charge-de-la-douleur-apres
2024
United Kingdom
review of literature
french abstract
pain
child, nos
Pain Therapy
During or After
Status Post
ibuprofen
pain management
risks and benefits
Surgical Procedure
pain, nos
operative procedure, nos
child
What Month is it
Child Relation
surgical procedures, operative
Ibuprofen
risk-taking
risk assessment
Operation
ibuprofen
Child Individual
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1368
2024
France
public health guidelines
Ventilation
Neither Agree or Disagree
administration, topical
Theophylline
Localized Disease
hygiene
Location of Oral Residue Following Swallowing
attentiveness
Location of Pharyngeal Residue Following Swallowing
risk
Relative Value
judgment
Local-Regional
Anatomic Site
ventilation
Usage
epidemics
ventilation, nos
Locally
with cleaniless
Epidemic Disorder
Usually Need Help from Another Person for Hygiene
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1369
2024
France
guideline
Neither Agree or Disagree
usutu virus
Virus
simian immunodeficiency virus
homo sapiens
risk
judgment
humans
Disease Transmission
Usutu virus
bone screws
Supplies
Usutu virus
Human Origin
---
https://www.has-sante.fr/jcms/p_3497216/fr/labellisation-par-la-has-d-un-flash-securite-patient-elabore-par-un-organisme-externe
2024
France
guideline
Scientific Equipment
outpatients
Professional Practice
organ part
tool, nos
professional practice
Outpatient
Safety
organizations
Improved
CASP8AP2 wt Allele
Whole Organism
patient safety
Tool
Enhance
Organism Part
societies
has patient
Labeled
Safety Study
---
https://iris.who.int/handle/10665/376078
2024
Switzerland
technical report
Paraneoplastic Syndrome is Not Present
communicable disease control
Caffeine Not Routinely Consumed
Has No Sibling
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Chief Complaint Not Caused by Trauma
Local Anesthesia Agents were not Administered
health personnel
Radiation History Negative
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Physician Diagnosed Diabetes Absent
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Additional Surgery for New Tumor Event Absent
principal
Chemical/Occupational Exposure Absent
EGFR Gene Amplification Negative
EGFR Amplification Analysis Was Not Performed
Cancer History Absent
Preoperative IV Antiemetics were not Administered
New Tumor Event After Initial Treatment Absent
Minor Criteria for Rheumatic Heart Disease Not Present
Therapeutic Ionizing Radiation to Head History Absent
Optimization
PTEN Gene Mutation Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
PDGFRA Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
10q23/PTEN Locus Deletion Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
Not Lost to Follow-Up
NON Mouse
Another Form of Birth Control was not Used
No History of Congenital Heart Disease
ATRX Gene Mutation Negative
Improved
Medication Not Taken
First Degree Family History of Primary Brain Tumor Negative
No History of Non-Cardiac Surgery
Preoperative IV Sedation was Not Administered
First Degree Family History Thyroid Cancer Negative
Regional Anesthesia was not Administered
Any Metastatic Diagnosis Absent
delivery of health care
1p/19q Deletion Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
BRAF Mutation Analysis Was Not Performed
Negation
Neither Case or Control Status
kenya
Chemotherapy Not Received
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Health Care Delivery
Noncommunicable Diseases
EGFR Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
No History of Myopathy
Delegate Action
First Degree Family History Cancer Negative
PTEN Mutation Analysis Was Not Performed
Enhance
health services
Additional Immunohistochemistry Was Not Performed
KRAS Mutation Analysis Was Not Performed
health benefits
Chief Complaint was Not Witnessed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Primary Care
Unemployed
Lymph Node Dissection Was Not Performed
History of Medical Treatment Absent
SDH Complex Mutation Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
IDH Family Wildtype
Radiation Therapy Not Received
IV Anesthesia was not Administered
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
No History of Kawasaki Disease
No History of Neonatal Complication
Norway
No Response to Intervention for Kawasaki Disease
ALK Rearrangement Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
New Disease is not Multifocal
Preoperative IV Opiates were not Administered
No Known History of Alcohol Use
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Tumor Progression Absent After Initial Treatment
RET Rearrangement Analysis Was Not Performed
Share
Documentation Absent
Shared
primary health care
State or Local Health Department
Additional Molecular Studies Were Not Performed
NRAS Mutation Analysis Was Not Performed
insurance benefits
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Adjuvant I-131 Therapy Negative
MET Mutation Analysis Was Not Performed
Research Personnel
BRAF Rearrangement Analysis Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Preoperative IV Antacids were not Administered
No Known History of Illicit Drug Use
MGMT Promoter Methylation Testing Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
ERBB2 Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Hypertension Absent
On Staff
Care Of
No History of Rheumatic Fever
History of Colorectal Cancer Negative
NF1 Mutation Analysis Was Not Performed
Nitric Oxide
No History of Gestational Complication
TP53 Mutation Analysis Was Not Performed
personnel delegation
KIT Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
communicable disease, nos
ATRX Mutation Analysis Was Not Performed
Nitric Oxide Measurement
Use of Smokeless Tobacco at Time of Diagnosis Negative
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Intervention Not Given for Kawasaki Disease
primary health care
IDH Family Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Fluorescence In Situ Hybridization Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
Communicable Disorder
Patient was not Postmenopausal with no Prior Oophorectomy
Family History of Stomach Cancer Absent
Neither
Adjuvant Post-operative Chemotherapy Was Not Administered
---
https://www.has-sante.fr/jcms/p_3499384/fr/labellisation-par-la-has-d-un-flash-securite-patient-elabore-par-un-organisme-externe
2024
France
evaluation of the transparency committee
Handbook
methods
Safety Study
Organisms Category
PRETEXT Stage 4
patient safety
has patient
PRETEXT Stage 3
PRETEXT Stage 1
organ part
Safety
PRETEXT Stage 2
organizations
outpatients
Whole Organism
Organism Part
CASP8AP2 wt Allele
Guide Device
Outpatient
Labeled
---
https://www.has-sante.fr/jcms/p_3409204/fr/tetravac-acellulaire-vaccin-diphterique-tetanique-coquelucheux-acellulaire-poliomyelitique-inactive-adsorbe
2023
France
evaluation of the transparency committee
preventive immunization/medication
tetany, nos
Tetany
pertussis
vaccine, nos
diphtheria-tetanus vaccine
Diphtheria
Vaccins
vaccination
whooping cough
poliomyelitis
Whooping cough
whooping cough
diphtheria, nos
Vaccinia
vaccines, acellular
poliomyelitis
---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101185/n/strategies-gestion-sante-securite
2023
Canada
technical report
Employment
injury, nos
safety management
safety, occupational
Labor ; manpower ; population
review literature as topic
return to work
unemployment
occupational health
occupational injuries
small business
occupation, nos
Literature
employment
entrepreneurship
Work safety
---
https://www.ineris.fr/fr/guide-strategie-prelevements-analyses-realiser-suite-accident-technologique-cas-incendie-0
2023
France
technical report
technology
achievement
due to
accidents
Technology
accident, nos
Handbook
fires
---
https://publication-theses.unistra.fr/public/theses_exercice/MED/2022/2022_CHEVRIAUX_Amandine.pdf
2023
France
dissertations, academic
Literature
primary health care
principal
primary prevention
primary health care
child, nos
child, gifted
consultants
tool, nos
Child
referral and consultation
Child
Early Intervention, Educational
review literature as topic
early diagnosis
Child
early medical intervention
nursing
due to
Child
---
https://drees.solidarites-sante.gouv.fr/sources-outils-et-enquetes/donnees-sur-la-situation-financiere-des-organismes-complementaires
2023
France
scientific and technical information
Insurance
health
insurance coverage
organ donation
tissue and organ procurement
Organism
insurance, major medical
organ part
---
https://ansm.sante.fr/tableau-marr/daratumumab
2023
false
false
false
France
French
guideline
patient education handout
risk management
daratumumab
daratumumab
Laboratory test related to immunohematology (procedure)
Laboratory test interference
immunologic tests
hematologic tests
---
https://ansm.sante.fr/tableau-marr/ciltacabtagene-autoleucel
2023
false
false
false
France
French
risk management
guidelines for drug use
patient education handout
Ciltacabtagene Autoleucel
infusions, intravenous
immunotherapy, adoptive
Product containing genetically modified T-cell (product)
Receptors, Chimeric Antigen
Cytokine Release Syndrome
continuity of patient care
Ciltacabtagene Autoleucel
neurotoxicity syndromes
drug compounding
ciltacabtagene autoleucel
---
https://ansm.sante.fr/tableau-marr/rivaroxaban
2023
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording
---
https://ansm.sante.fr/tableau-marr/apixaban
2023
false
false
false
France
French
guidelines for drug use
risk management
apixaban
administration, oral
apixaban
continuity of patient care
hemorrhage
Drug-Related side effects and adverse reactions
patient education handout
---
https://ansm.sante.fr/tableau-marr/axicabtagene-ciloleucel
2023
false
false
false
France
French
risk management
axicabtagene ciloleucel
guidelines for drug use
axicabtagene ciloleucel
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
nervous system diseases
patient education handout
signs and symptoms
axicabtagene ciloleucel
infusions, intravenous
gene therapy
---
https://ansm.sante.fr/tableau-marr/brexucabtagene-autoleucel
2023
false
false
false
France
French
risk management
brexucabtagene autoleucel
genetic therapy
gene therapy
Cytokine Release Syndrome
signs and symptoms
guidelines for drug use
patient education handout
Drug-Related side effects and adverse reactions
nervous system diseases
brexucabtagene autoleucel
brexucabtagene autoleucel
---
https://ansm.sante.fr/tableau-acces-derogatoire/oxbryta-voxelotor
2023
false
false
false
France
French
risk management
voxelotor
voxelotor
administration, oral
hematologic agents
drug information
anemia, hemolytic
anemia, sickle cell
---
https://ansm.sante.fr/tableau-marr/abrocitinib
2023
false
false
false
France
French
risk management
abrocitinib
abrocitinib
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patient education handout
---
https://ansm.sante.fr/tableau-marr/brolucizumab
2023
false
false
false
France
French
risk management
brolucizumab
intravitreal injections
patients guideline
drug information
---
https://ansm.sante.fr/tableau-marr/avalglucosidase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
Infusion-Related Reaction
medication errors
Avalglucosidase Alfa
infusions, intravenous
home infusion therapy
continuity of patient care
enzyme replacement therapy
GAA protein, human
avalglucosidase alfa
monitoring, immunologic
glycogen storage disease type ii
---
https://ansm.sante.fr/tableau-marr/agalsidase-beta
2023
false
false
false
France
French
risk management
agalsidase beta
guidelines for drug use
patients guideline
infusions, intravenous
enzyme replacement therapy
fabry disease
continuity of patient care
home health nursing
---
https://ansm.sante.fr/tableau-marr/methoxyflurane
2023
false
false
false
France
French
risk management
methoxyflurane
administration, inhalation
guidelines for drug use
methoxyflurane
methoxyflurane
Drug-Related side effects and adverse reactions
emergency treatment
pain
wounds and injuries
Post-traumatic pain
---
https://ansm.sante.fr/tableau-marr/asfotase-alfa
2023
false
false
false
France
French
risk management
guidelines for drug use
asfotase alfa
asfotase alfa
self administration
patients guideline
child
injections, subcutaneous
enzyme replacement therapy
asfotase alfa
hypophosphatasia
---
https://ansm.sante.fr/tableau-marr/atidarsagene-autotemcel
2023
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
Atidarsagene Autotemcel
risk management
infusions, intravenous
gene therapy
atidarsagene autotemcel
biological products
---
https://ansm.sante.fr/tableau-marr/onasemnogene-abeparvovec
2023
false
false
false
France
French
guidelines for drug use
risk management
Zolgensma
onasemnogene abeparvovec
infusions, intravenous
patients guideline
child
spinal muscular atrophies of childhood
onasemnogene abeparvovec-xioi
biological products
recombinant fusion proteins
---
https://ansm.sante.fr/tableau-marr/eculizumab
2023
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout
---
https://ansm.sante.fr/tableau-marr/baclofene
2023
false
false
false
France
French
baclofen
baclofen
risk management
guidelines for drug use
patients guideline
patient education handout
continuity of patient care
drug monitoring
alcoholism
---
https://ansm.sante.fr/tableau-marr/propranolol
2023
false
false
false
France
French
risk management
propranolol
propranolol hydrochloride
administration, oral
guidelines for drug use
patients guideline
child
Drug-Related side effects and adverse reactions
bronchial spasm
hypoglycemia
convulsive seizures
adrenergic beta-antagonists
hemangioma, capillary
propranolol
---
https://ansm.sante.fr/tableau-marr/darbepoetin-alfa
2023
false
false
false
France
French
risk management
Darbepoetin alfa
darbepoetin alfa
hematinics
self administration
Self-administration error
patients guideline
checklist
injections
guidelines for drug use
---
https://www.cismef.org/cismef/wp/wp-content/uploads/2023/11/Système-National-des-Données-de-Santé-presentation-V2.pdf
2023
false
false
false
false
true
France
French
medical informatics
delivery of health care
educational course
insurance, health
databases as topic
data collection
1.3.2 Knowing the specifics of health data storage [National Health Data System (SNDS)
and health data warehouses]
data collection
databases
Medical Informatics
---
https://publications.msss.gouv.qc.ca/msss/document-002140/
2023
false
false
false
Canada
popular works
immunization
quebec
influenza, nos
health
health personnel
Program
Examination Questions
Intertrochanteric fracture
vaccination, nos
immunization programs
intention
influenza, human
immunization
health
---
https://www.medsubhyp.fr/recommandations-en-sante-au-travail/
2023
false
false
false
France
French
consensus
adolescent
adult
pregnancy
hematologic diseases
cardiovascular diseases
respiratory tract diseases
eye diseases
skin diseases
tooth diseases
kidney diseases
gastrointestinal diseases
musculoskeletal diseases
otorhinolaryngologic diseases
occupational medicine
occupational medicine
occupational health physicians
return to work
government regulation
signs and symptoms
aged
hearing tests
respiratory function tests
risk assessment
accidents
barotrauma
barotrauma
occupational exposure
central nervous system diseases
occupational medicine
submarine medicine
mental disorders
work capacity evaluation
---
http://publications.msss.gouv.qc.ca/msss/document-002124/
2023
false
false
false
Canada
French
antineoplastic agents
infusions, intravenous
safety management
neoplasms
injections, intravenous
drug compounding
quebec
antineoplastic agents
guideline
nurses, male
professional role
infusions, intravenous
injections, intravenous
Infusion Pumps
extravasation of diagnostic and therapeutic materials
antineoplastic agents
protective clothing
occupational exposure
patient safety
catheterization, central venous
---
https://ansm.sante.fr/tableau-marr/teriflunomide
2023
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines
---
https://ansm.sante.fr/tableau-marr/alemtuzumab
2023
false
false
false
France
French
risk management
Alemtuzumab
Alemtuzumab
alemtuzumab
infusions, intravenous
continuity of patient care
multiple sclerosis, relapsing-remitting
guidelines for drug use
patients guideline
patient education as topic
Drug-Related side effects and adverse reactions
drug monitoring
clinical chemistry tests
thyroid diseases
purpura, thrombocytopenic, idiopathic
kidney diseases
anti-glomerular basement membrane disease
Infections
pregnancy
mass screening
Contraindications, Drug
premedication
---
https://ansm.sante.fr/tableau-marr/alitretinoine
2023
false
false
false
France
French
guidelines for drug use
patients guideline
forms
administration, oral
teratogens
pregnancy
contraception
alitretinoin
mental disorders
dyslipidemias
continuity of patient care
pancreatitis
transaminases
Chemical and Drug Induced Liver Injury
drug monitoring
risk management
clinical chemistry tests
patient education handout
tretinoin
tretinoin
Alitretinoin
Alitretinoin
---
https://ansm.sante.fr/tableau-marr/deferasirox
2023
false
false
false
France
French
administration, oral
risk management
medication errors
guidelines for drug use
patient education handout
continuity of patient care
Deferasirox
---
https://ansm.sante.fr/tableau-marr/emicizumab
2023
false
false
false
France
French
emicizumab
risk management
thromboembolism
hemorrhage
thrombotic microangiopathies
blood coagulation tests
risk
hemorrhage
hemophilia A
patients guideline
guidelines for drug use
handbooks
Drug-Related side effects and adverse reactions
injections, subcutaneous
emicizumab
antibodies, bispecific
antibodies, monoclonal, humanized
---
https://ansm.sante.fr/tableau-marr/levonorgestrel-diu
2023
false
false
false
France
French
administration, intravaginal
levonorgestrel
risk management
patient education handout
intrauterine devices, medicated
plastic iud with progestogen
pregnancy, ectopic
risk
guideline
Insertion of intrauterine contraceptive device (procedure)
Contraceptive Effectiveness
---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2023
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
---
https://ansm.sante.fr/tableau-marr/rituximab
2023
false
false
false
France
French
risk management
Rituximab
Rituximab
infusions, intravenous
injections, subcutaneous
rituximab
guidelines for drug use
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
patient education handout
drug compounding
---
https://ansm.sante.fr/tableau-marr/rituximab-1
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
infusions, intravenous
rituximab
medication errors
guidelines for drug use
patient education handout
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
---
https://ansm.sante.fr/tableau-marr/rituximab-2
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
infusions, intravenous
rituximab
leukoencephalopathy, progressive multifocal
Infections
medication errors
continuity of patient care
---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2023
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2023-6-9-fevrier
2023
false
false
false
France
French
drug information
risk assessment
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)
vasoconstrictor agents
administration, oral
---
https://www.cochrane.org/fr/CD010693/STROKE_des-medicaments-antidiabetiques-dans-la-prevention-des-accidents-vasculaires-cerebraux-et-autres
2023
United Kingdom
review of literature
french abstract
cerebral ischemia, transient
vascular disease, nos
Blood vessel
antidiabetics
transient cerebral ischemia, nos
stroke/cerebrovascular accident
drug, nos
ischemic attack, transient
cerebrovascular accident, nos
protective agents
blood vessels
accident, nos
stroke
persons
Ischemic Stroke
Diseases
vascular diseases
Ischemia
hypoglycemic agents
brain, nos
transient cerebral ischaemia
accident prevention
---
https://www.cochrane.org/fr/CD012974/SKIN_quels-sont-les-benefices-et-les-risques-du-traitement-neoadjuvant-traitement-medicamenteux-avant
2023
United Kingdom
review of literature
french abstract
kidnapping
risks and benefits
skin neoplasms
Tumors
malignant neoplasm of skin
neoplasms
Skin cancer
Tumors
Tumors
cancer of skin
Tumors
drug therapy
neoplasm, malignant
Tumors
Tumors
operative procedure, nos
Tumors
Tumors
Tumors
Tumors
Tumors
procedural approach, nos
surgical procedures, operative
drug, nos
Melanoma
crime
Tumors
risk assessment
melanoma
melanoma, cutaneous malignant
neoadjuvant therapy
---
https://www.cochrane.org/fr/CD013782/SYMPT_quels-sont-les-benefices-et-les-risques-de-lutilisation-de-corticosteroides-dans-le-traitement-de-la
2023
United Kingdom
review of literature
french abstract
risk assessment
neoplasms
fatigue
adrenal cortical hormone, nos
risks and benefits
cancer
neoplasm, malignant
Cancer
due to
adrenal cortex hormones
corticosteroid therapy
fatigue
---
https://dares.travail-emploi.gouv.fr/publication/les-salaries-des-entreprises-sous-traitantes-sont-ils-davantage-exposes-aux-accidents
2023
France
journal article
accidents, occupational
Labor ; manpower ; population
exposure to
work-related activity accident, nos
accident while engaged in work-related activity, nos
---
https://www.canada.ca/fr/sante-publique/services/publications/vie-saine/guide-canadien-immunisation-partie-1-information-cle-immunisation/page-15-contenu-agents-immunisants-utilises-canada.html
2023
false
false
false
Canada
scientific and technical information
immunization
canada
vaccination, nos
Handbook
---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2023
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec
---
https://ansm.sante.fr/tableau-marr/luspatercept
2023
false
false
false
France
French
guidelines for drug use
risk management
luspatercept
luspatercept
luspatercept
injections, subcutaneous
hematinics
hematinics
pregnancy
breast feeding
continuity of patient care
patient education handout
checklist
Female of Childbearing Potential
product surveillance, postmarketing
contraception
---
https://ansm.sante.fr/tableau-marr/idecabtagene-vicleucel
2023
false
false
false
France
French
guidelines for drug use
popular works
risk management
idecabtagene vicleucel
idecabtagene vicleucel
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
drug compounding
idecabtagene vicleucel
gene therapy
immunotherapy, adoptive
idecabtagene vicleucel
continuity of patient care
nervous system diseases
infusions, intravenous
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
multiple myeloma
Cytokine Release Syndrome
Cytokine Release Syndrome
signs and symptoms
---
https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/vaccines-immunization/national-advisory-committee-immunization-guidance-additional-covid-19-booster-dose-spring-2023-individuals-high-risk-severe-illness-due-covid-19/declaration.pdf
2023
Canada
public health guidelines
Vaccins
COVID-19 Vaccines
disease, nos
Vaccinia
COVID-19
vaccine, nos
severe
vaccination
guideline
risk
immunization, secondary
leadership
Diseases Category
disease
persons
preventive immunization/medication
Diseases
---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-2-3-fevrier-mars-2023/surveillance-sentinelle-surpasse-basee-risque-suivre-maladies-transmises-tiques.html
2023
Canada
journal article
canada
Diseases
Emerging disease
tick-borne diseases
sentinel surveillance
watchful waiting
risk
disease, nos
activir
Tick-borne disease
---
https://www.cochrane.org/fr/CD013176/GUT_quels-sont-les-benefices-et-les-risques-de-lerythromycine-administree-avant-une-endoscopie-chez-les
2023
United Kingdom
review of literature
french abstract
administration
Administration
endoscopy, nos
erythromycin, nos
Endoscopy
hemorrhage, nos
risk assessment
erythromycin
risks and benefits
persons
intestines
hemorrhage
administrative personnel
administrators
intestinal tract, nos
endoscopy
bloodletting
---
https://ansm.sante.fr/tableau-marr/ranibizumab-1
2023
false
false
false
France
French
risk management
patient education handout
Ranibizumab
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release
solution for injection (clinical drug)
intravitreal injections
---
https://apps.who.int/iris/handle/10665/366414
2023
Switzerland
journal article
future
Preparation
Techniques
Techniques
risk
epidemics
group processes
Techniques
Techniques
pandemics
forecasting
focus groups
organization and administration
---
https://www.cochrane.org/fr/CD014909/COLOCA_la-preparation-intestinale-combinee-mecanique-et-antibiotique-orale-peut-elle-reduire-le-risque-de
2023
United Kingdom
review of literature
french abstract
antibiotic, nos
intestines
Program
intestinal tract, nos
mechanics
albumin/globulin ratio
antibiotics
anti-bacterial agents
due to
large intestine, nos
Preparation
rectum
mouth, nos
Antibiotics
risk
research report
colon
excision, nos
complication, nos
---
https://www.irsst.qc.ca/publications-et-outils/publication-irsst/i/101187/n/risques-vibrations-mains-bras-secteur-minier
2023
Canada
popular works
vibration
risk
arm
identified
hand
vibration
---
https://www.has-sante.fr/jcms/p_3418538/fr/faire-la-check-list-materiel-48-heures-avant-toute-intervention-programmee
2023
France
scientific and technical information
Safety
Materials
tool, nos
appointments and schedules
patient safety
schedules, patient
professional practice
solutions
Practice
Solutions
has patient
occupational health
checklist
solution, nos
---
https://ansm.sante.fr/tableau-marr/caplacizumab
2023
false
false
false
France
French
popular works
risk management
continuity of patient care
hemorrhage
caplacizumab
caplacizumab
---
https://www.inspq.qc.ca/publications/3297-surveillance-securite-trois-premieres-doses-vaccin-covid-19
2023
Canada
technical report
COVID-19
vaccinia
vaccines
vaccine, nos
vaccination
watchful waiting
Safety
activir
COVID-19 Vaccines
Vaccinia
preventive immunization/medication
vaccination
safety
quebec
Vaccins
---
https://ansm.sante.fr/tableau-marr/upadacitinib
2023
false
false
false
France
French
risk management
upadacitinib
patient education handout
guidelines for drug use
upadacitinib
Drug-Related side effects and adverse reactions
administration, oral
upadacitinib
Janus Kinase Inhibitors
Janus Kinase Inhibitors
teratogens
pregnancy
continuity of patient care
herpes zoster
tuberculosis
neoplasms
embolism and thrombosis
Virus Reactivation
---
https://ansm.sante.fr/tableau-marr/tofacitinib
2023
false
false
false
France
French
risk management
tofacitinib
tofacitinib
continuity of patient care
checklist
guidelines for drug use
patient education handout
Janus Kinase Inhibitors
tofacitinib
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
pregnancy
teratogens
Virus Reactivation
tuberculosis
neoplasms
embolism and thrombosis
herpes zoster
---
https://www.has-sante.fr/jcms/p_3423882/fr/flash-securite-patient-les-medicaments-en-pediatrie-ce-n-est-pas-un-jeu-d-enfant
2023
France
scientific and technical information
Child
Child
has patient
prion diseases
pediatrics
Safety
child
Child
pharmaceutical preparations
pediatrician
patient safety
child, nos
Child
drug, nos
---
https://ansm.sante.fr/tableau-marr/baricitinib
2023
false
false
false
France
French
risk management
guidelines for drug use
patient education handout
baricitinib
baricitinib
continuity of patient care
Janus Kinase Inhibitors
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
baricitinib
---
https://eurogip.fr/wp-content/uploads/2023/03/EUROGIP-Teletravail-et-accident-de-travail-en-Europe.pdf
2023
France
technical report
work-related activity accident, nos
accidents, occupational
accident while engaged in work-related activity, nos
Labor ; manpower ; population
Teleworking
---
https://ordomedic.be/fr/avis/deontologie/secret-professionnel/patient-d%C3%A9c%C3%A9d%C3%A9---informations-pour-la-compagnie-dassurances
2023
Belgium
scientific and technical information
patient given information
Insurance
insurance carriers
consumer health information
---
https://www.inspq.qc.ca/publications/3312
2023
Canada
technical report
medical devices
equipment and supplies
retirement, nos
research report
Handbook
device, nos
albumin/globulin ratio
accidents
accident, nos
retirement
incidence
---
https://www.cochrane.org/fr/CD010590/RENAL_la-securite-et-lefficacite-relatives-de-differents-medicaments-base-depoetine-dans-le-traitement-de
2023
United Kingdom
review of literature
french abstract
chronic renal failure syndrome, nos
anemia
Renal failure
pharmaceutical preparations
due to
anemia, nos
erythropoietin
Safety
renal insufficiency, chronic
Chronic renal failure
drug, nos
safety
efficiency
Anemia
base, nos
persons
---
https://www.irdes.fr/recherche/2023/rapport-587-faisabilite-d-identification-des-personnes-a-risque-de-handicap-fish.html
2023
France
technical report
general practitioners
limited function/disability nos
risk assessment
in situ hybridization, fluorescence
General methodology
Organism
health
methods
Organisms Category
Methodology
medical futility
risk
organizations
Handicap
organ part
Data Systems
delivery of health care
disabled persons
algorithms
De-Identification
resulting in
handicap
Disability
Handicap
---
http://nuxeo.edel.univ-poitiers.fr/nuxeo/site/esupversions/1e2d269f-e531-4d95-9ff7-abe0a682e12f
2023
France
dissertations, academic
patients
adulthood
Adult
Lipids
principal
disease, nos
disease
Diseases
adult
Lipids
review literature as topic
has patient
Adult
Lipids
lipids measurement
lipids
primary prevention
health planning guidelines
Literature
Disease
---
http://nuxeo.edel.univ-poitiers.fr/nuxeo/site/esupversions/958d0308-fa99-4733-acfc-6fa0cc040a81
2023
France
dissertations, academic
Physicians
primary prevention
internal medicine
pediatrics
pediatrician
internal medicine specialist
general practitioners
principal
Pediatricians
preventive medicine
data collection
general physician, nos
Regions
general practice
---
https://athena.u-pec.fr/primo-explore/search?query=any,exact,998324964704611&vid=upec
2023
France
dissertations, academic
valine
primary prevention
albumin/globulin ratio
burnout, professional
Occupational burnout
physical and emotional exhaustion state
principal
Physicians
general practitioners
research report
---
https://dumas.ccsd.cnrs.fr/dumas-04016494
2023
France
dissertations, academic
drug interactions
social justice
Physicians
drug evaluation
general practice
drug interaction
counseling
risk assessment
De-Identification
phytotherapy
common good
symptom assessment
---
https://dumas.ccsd.cnrs.fr/dumas-04050021
2023
France
dissertations, academic
has patient
depressive disorder
containment of biohazards
depressive disorder, nos
Anxiety disorders
patients
COVID-19
anxiety disorder, nos
consultants
Anxiety disorder
depressive disorder
anxiety disorders
psyche, nos
Physicians
general practice
Anxiety disorders
---
https://www.has-sante.fr/jcms/p_3426554/fr/experimentation-de-l-indicateur-de-qualite-et-de-securite-des-soins-du-theme-des-infections-associees-aux-soins-couverture-vaccinale-antigrippale-du-personnel-hospitalier
2023
France
technical report
Safety
safety
suggestive of
nursing
infectious disease, nos
Infectious disease
indication of
personnel, hospital
quality indicators, health care
cross infection
Vaccination Coverage
Infections
hospital, nos
---
https://ansm.sante.fr/tableau-marr/adrenaline
2023
false
false
false
France
French
risk management
guidelines for drug use
epinephrine
epinephrine
Self injection
self administration
patient education handout
---
https://ansm.sante.fr/tableau-marr/alglucosidase-alpha
2023
false
false
false
France
French
guidelines for drug use
risk management
alpha-Glucosidases
alpha-Glucosidases
alpha-Glucosidases
---
https://www.cochrane.org/fr/CD013258/MUSKINJ_reduire-les-risques-de-chute-dans-lenvironnement
2023
United Kingdom
review of literature
french abstract
risk
hazardous substances
fall, nos
accidental falls
environment
Environment
---
https://www.cochrane.org/fr/CD001211/EYES_quels-sont-les-benefices-et-les-risques-des-antibiotiques-dans-le-traitement-de-la-conjonctivite
2023
United Kingdom
review of literature
french abstract
anti-bacterial agents
antibiotic, nos
conjunctivitis, bacterial
Antibiotics
risks and benefits
bacterium, nos
antibiotics
antibiotic therapy
risk assessment
acute conjunctivitis, nos
Conjunctivitis
---
https://ansm.sante.fr/tableau-marr/ravulizumab
2023
false
false
false
France
French
risk management
ravulizumab
ravulizumab
ravulizumab
infusions, intravenous
guidelines for drug use
patients guideline
continuity of patient care
meningococcal infections
sepsis
neisseria meningitidis
vaccination
antibiotic prophylaxis
meningococcal infections
sepsis
child
infant
hemoglobinuria, paroxysmal
Atypical Hemolytic Uremic Syndrome
myasthenia gravis, generalized
---
https://www.academie-medecine.fr/des-ongles-brillants-mais-pas-sans-risque/
2023
France
scientific and technical information
risk
systolic pressure
Jails
nails
---
https://www.cochrane.org/fr/CD015333/ENT_quels-sont-les-benefices-et-les-risques-des-traitements-autres-que-medicamenteux-des-vertiges
2023
United Kingdom
review of literature
french abstract
postural vertigo, nos
drug, nos
Other treatments
risks and benefits
vertigo
drug therapy
Vertigo
risk assessment
---
https://www.health.belgium.be/fr/publication-securite-des-transports-2018-2022
2023
Belgium
technical report
transportation
safety
Safety
Transports
Transports
---
https://www.irsst.qc.ca/publications-et-outils/video/i/100519/n/facteurs-sentiment-injustice-accident-travail
2023
Canada
congresses
audiovisual material
emotion, nos
due to
accidents, occupational
postman
Labor ; manpower ; population
work-related activity accident, nos
accident while engaged in work-related activity, nos
---
https://www.e-cancer.fr/Presse/Dossiers-et-communiques-de-presse/Risques-solaires-pendant-l-enfance-l-ombre-l-endroit-le-plus-cool-du-printemps
2023
France
popular works
childhood
shadow, nos
risk
solar energy
salmonidae
---
https://ansm.sante.fr/tableau-marr/faricimab
2023
false
false
false
France
French
risk management
faricimab
risk
patient education handout
faricimab
intravitreal injections
Drug-Related side effects and adverse reactions
signs and symptoms
wet macular degeneration
diabetic retinopathy
Macular edema due to diabetes mellitus (disorder)
patients guideline
sound
---
https://www.inrs.fr/media.html?refINRS=outil112
2023
France
software
risk assessment
tool, nos
Pharmacy
pharmacy
---
https://www.who.int/fr/publications-detail/9789240073074
2023
Switzerland
technical report
mental disorders
Insurance
underinsured
problem, nos
significant other
patient participation
mental health
medically uninsured
Neurology
Mental health
Mental health
world health organization
insurance, health
mentally ill persons
neurology
nervous system diseases
deductibles and coinsurance
Disease
Diseases
communicable disease, nos
Noncommunicable Diseases
---
https://ansm.sante.fr/tableau-marr/elosulfase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
elosulfase alfa
elosulfase alfa
infusions, intravenous
infusion rate
drug dosage calculations
---
https://www.youtube.com/watch?v=19azkJxgm-8
2023
France
congresses
audiovisual material
accidents, occupational
work-related activity accident, nos
Labor ; manpower ; population
accident while engaged in work-related activity, nos
---
https://dumas.ccsd.cnrs.fr/dumas-04064495
2023
France
social networks
detective
behavior, addictive
social support
data collection
general practitioners
dependent drug abuse
population
Addictive behaviors
COVID-19
group processes
Addictive behaviors
containment of biohazards
General populations
Addiction
---
